NorthStar Medical Radioisotopes has broken ground on a new 50,000-sq-ft facility in Beloit, WI, that will house its new headquarters and molybdenum-99 (Mo-99) production activities.
The new facility is the first phase in the planned development of a 32-acre corporate campus for NorthStar, according to the firm. It will support the company's work at the University of Missouri Research Reactor (MURR) in Columbia, MO, where NorthStar is developing a neutron capture process to generate Mo-99.
The facility, scheduled for completion later this year, will provide ancillary processes, packaging, and products, including final assembly and testing of the proprietary RadioGenix intelligent isotope separation system, the company said. NorthStar is pursuing two nonuranium- and nonfission-based production processes that would help establish the first domestic source of Mo-99 since 1990.
The firm will also move its headquarters from Madison, WI, to the Beloit facility.
